Puresu customised assemblies offer a unique range of benefitsNew solutions to customers with different bioprocessing needs
Watson-Marlow Fluid Technology Group’s puresu single-use tube assemblies offer reliable, sterile, customisable solutions for bioprocessing. The expanded product range offers tailor-made solutions for customers with specific bioprocessing requirements.
Watson-Marlow Fluid Technology Group (WMFTG) announces the expansion of its puresu single-use range, providing a combination of components that are safe and easy-to-install. Puresu is ideal for the end-to-end manufacture of biopharmaceuticals and personalised medicines, such as gene therapies. The expanded range consists of three new product options: sterile claim, gamma irradiated and non-irradiated.
WMFTG’s puresu assemblies offer a unique solution to the challenges of bioprocessing, providing controlled, efficient and reliable single-use assemblies that simplify validation processes. Offering open architecture design, by using the single-use components customers can quickly create a sterile fluid path that meets their